|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910822216103321 |
|
|
Titolo |
Treatments for neurodevelopmental disorders : targeting neurobiological mechanisms / / edited by Randi Jenssen Hagerman and Robert L. Hendren |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Oxford, England ; ; New York : , : Oxford University Press, , 2014 |
|
©2014 |
|
|
|
|
|
|
|
|
|
ISBN |
|
0-19-937888-6 |
0-19-937987-4 |
0-19-993781-8 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (401 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Nervous system - Diseases |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references at the end of each chapters and index. |
|
|
|
|
|
|
|
|
Nota di contenuto |
|
Cover; Treatment of Neurodevelopmental Disorders; Copyright; Contents; Foreword; Overview of Neurodevelopmental Processes and the Assessment of Patients with Neurodevelopmental Disorders; Autism: Neurobiological Mechanisms and Targeted Treatments; Targeted Treatments in Schizophrenia; Neurodevelopmental and Neurobiological Aspects of Major Depressive Disorder; Attention-Deficit Hyperactivity Disorder; Targeted Treatments in Rett Syndrome; Cardio-Facio-Cutaneous Syndrome and Other RASopathies; Targeted Treatments in Tuberous Sclerosis Complex (TSC) |
Treatment of Fragile X Syndrome and Fragile X-associated DisordersAngelman Syndrome; Pharmacotherapy for Cognitive Enhancement in Down Syndrome; Targeted Treatments for Phenylketonuria; Muscular Dystrophies; Translating Treatments from the Laboratory to the Clinic; Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This cutting-edge book brings advances in genetics, neurobiology, and psychopharmacology to the clinic to enhance treatment for neurodevelopmental disorders. Significant progress has been made in identifying the neurobiological mechanisms of several disorders and targeted treatments are modifying the outcome of these disorders. |
|
|
|
|